chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID 19 Treatment; COVID 19 Treatment; Rebound; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  An 81-year-old male patient received BNT162b2 (BNT162B2), on 24May2022 at 13:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 81 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DISEASE RECURRENCE (medically significant) with onset 24Aug2022 at 07:00, outcome "recovering", described as "Rebound"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19. Therapeutic measures were not taken as a result of disease recurrence. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information provide and plausible temporal association, the causality between BNT162B2 and events cannot be completely excluded.
11/15 watery conjuctivitis, Tobrex drops rx'd thru 11/20; 11/16 cranky, whiny all day, sleeps poorly; 11/19 fever 100, resolved at home; 11/20 fever 103, Childrens Advil given 1.5 days; 11/22 rash on trunk, dr attributes to vaccine;
Information has been received from a licensed practical nurse, concerning a 64 year old male patient with no known drug reactions/allergies and no pertinent medical history, who on 25-OCT-2008, was vaccinated with PNEUMOVAX (lot # 659150/1384U) 0.5 ml, intramuscularly. Concomitant therapy included influenza virus vaccine (unspecified) (manufacturer unknown). The nurse reported that after receiving the vaccine, the patient developed blisters, redness and shedding of skin approximately 4 to 5 cm away from the injection site. The patient sought medical attention and was seen by the physician. At the time of this report, the patient was recovering. Follow-up information received from the licensed practical nurse indicated the he was a 64 year old male patient, weighing 226 pounds and 5' 10'' in height, with no known drug reactions/allergies. The licensed practical nurse stated that the patient called office and came for exam on 27-OCT-2008, complaining of increased injection site redness and blistering. The patient was seen again on 28-OCT-2008 and redness and blisters continued. Detected blisters near bottom of affected area with yellowish drainage using SILVADENE cream. On 30-OCT-2008, the patient was referred to a dermatologist. On 05-NOV-2008, a call was placed to the patient who stated that his arm was improving and did not complain of pain. Redness and blisters were considered to be an other important medical event by the reporter. Additional information is not expected.
Left upper and lower arm moderately swollen with warmth and redness. Tx with BENADRYL 1 tsp Q 6 hours and use cool compresses for swelling.
extremely flaky skin; burning and tingling on her arms, abdomen, and thighs; burning and tingling on her arms, abdomen, and thighs; burning and tingling on her arms, abdomen, and thighs; This spontaneous case was reported by a consumer and describes the occurrence of SKIN EXFOLIATION (extremely flaky skin), ABDOMINAL DISCOMFORT (burning and tingling on her arms, abdomen, and thighs), PARAESTHESIA (burning and tingling on her arms, abdomen, and thighs) and PAIN IN EXTREMITY (burning and tingling on her arms, abdomen, and thighs) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013m20a) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SKIN EXFOLIATION (extremely flaky skin), ABDOMINAL DISCOMFORT (burning and tingling on her arms, abdomen, and thighs), PARAESTHESIA (burning and tingling on her arms, abdomen, and thighs) and PAIN IN EXTREMITY (burning and tingling on her arms, abdomen, and thighs). At the time of the report, SKIN EXFOLIATION (extremely flaky skin), ABDOMINAL DISCOMFORT (burning and tingling on her arms, abdomen, and thighs) and PAIN IN EXTREMITY (burning and tingling on her arms, abdomen, and thighs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        No treatment information was provided
Symptoms - ? Patient reports itchiness to bilateral hands approximately 25 mins after vaccination, denies rash.  Patient reports she struggles with allergies and prophylactically medicated prior to first dose with 50 mg of Benadryl and Xytal.  Patient reports no adverse reaction after 1st vaccine.  Patient reports she prophylactically medicated last night as well but only took 25 mg and no Xytal, patient endorses she believes that is the difference in her symptoms between the first and second dose.  Patient endorses allergies to high dose Vitamin D (50,000 units).  Patient denies difficulty breath or SOB at this time.  Patient reports she is able to move freely at this time. Last day of work and shift - ? currently working at home today Home remedies? -   50 mg Benadryl at 08:00 and Pepcid and Xytal at 11:20 (did not disclose dosage) Any improvement? ? Patient reports mild improvement Recommendation? Patient encouraged to take allergy medication as directed and to call vaccine support if symptoms worsen.  Patient educated to call 911 or seek immediate care if any airway issues or difficulty breathing.
The pt experienced redness, swelling and warmth at the site of injection to the left thigh. Redness measured 11 x 11 cm. The pt was seen by an MD. Treated with cold compresses and Benadryl.
everything tastes salty; slight soreness at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of TASTE DISORDER (everything tastes salty) and VACCINATION SITE PAIN (slight soreness at the site of injection) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced TASTE DISORDER (everything tastes salty). 05-Mar-2021, the patient experienced VACCINATION SITE PAIN (slight soreness at the site of injection). At the time of the report, TASTE DISORDER (everything tastes salty) and VACCINATION SITE PAIN (slight soreness at the site of injection) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   Reporter did not allow further contact
SYMPTOMS: HEADACHE, CHILLS CHEST AND ARM PAIN FEVER DIZZINESS TEMPORARY EVOLUTION: THE FEVER DOWN A LITTLE, IT IS NO LONGER HAVING CHILLS. STILL HAVE ARM AND HEAD PAIN
Area extends about 4" from and below vaccination site. Two days ago (8 days from receiving vaccine), area began to itch, discovered small irregular lumps under skin. Today the area is very red and small lumps seem to have diminished into a hardness; arm is still sore to the touch.
Initial unsolicited report received from a nurse on 20 October 2015. This case was linked to 2015SA169848, 2015SA169859, 2015SA169865 and 2015SA169870. This case involves a female patient (age not reported) who was vaccinated with a dose of Fluzone QIV (batch number: U5321BA, expiration date: 30 June 2016, dose, dose number, route and site of administration were not reported) on 9 October 2015. The patient's medical history and concomitant medication were not reported.  On an unspecified date following the vaccination, the patient experienced rash and localized reaction. Laboratory investigation and corrective treatment were not reported. The outcome of the event was not reported. Documents held by sender: none. Follow-up information received from a nurse on 22 January 2016. This case involves a 50-year-old Patient who's family history includes heart disease and patient had no history of reaction to the flu vaccine. Patient's concomitant medication includes PAROXETINE, MICROZIDE and LOVASTATIN. On 9 October 2015, same day following the vaccination the patient experienced edema and redness to the left deltoid, patient also reported area became red with pain at injection site and had progressively gotten worse over the weekend. It was reported that patient regularly exercises does self-Brest examination, Mammogram and Pap smear.
Woke up at ~1:34AM with the same chest pains and extremity feelings as previous heart attack. Waited it out, continued until after 8am, slowly receding . Lingering effect include fatigue and extremities (arms) feeling weak and tingly
Scattered hives to forearm, knee, & calf.  She took 50 mg of Benadryl prior to vaccine, & another 100 mg post vaccine.
3 days after the vaccination, I was working and seated and suddenly I had a sensation of falling straight down. It continues at least 3/4 times a day and in April I had two days where I couldn't walk, I went to an urgent care on the last week of April bc I thought I had an ear infection. I had motion sickness from the dizziness I fell 05/01/2021 and my primary doctor referred to get an MRI of my brain and my abdomen because of how I fell and the bruising. I've been under the care of the Neurologist since June 2021 and started a RX Emgality and that is how they found out that I had migraines bc of the symptoms going right away after taking the medication. I see them regularly about the medication. The symptoms do come back every 23 days with the Emgality.
No reaction. Inappropriate administration. Patient received bivalent booster instead of 1st dose in primary series
Information has been received from a certified medical assistant concerning 6 unspecified patients of unknown age and gender. No pertinent medical history, drug reactions, allergies or concurrent conditions were reported. On unspecified dates, the patients were vaccinated with unspecified improperly stored doses of PROQUAD (lot number L046510 with an expiration date of 19-MAY-2017 (strength, dosage schedule, route and anatomical location were not reported). No other suspect and concomitant medications were provided. There was no adverse effect reported. No product quality complaint was involved. This is one of the several reports received from the same reporter. Additional information has been requested.
Flu; Initial information was received on 13-Oct-2020 regarding an unsolicited valid non-serious case from a social media via patient (consumer or non-health care professional).   This case involves patient with unknown demographics who experienced flu (influenza), while patient received vaccine INFLUENZA VACCINE.  At the time of reporting, patient reported that he is allergic to flu shot. The patient had flu shot (influenza vaccine) in past and had Flu (influenza) as adverse event.  Medical history, medical treatment, family history and concomitant medication were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number and expiry date not reported) via an unknown route at unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, the event outcome reported as unknown for influenza.   There will be no information available on the batch number for this case.
May 3, 2016 when I first went to Dr for a physical and was given a pneumonia shot on this visit in the muscle left upper arm. On May 4 my upper left arm was very painful, could not lift my arm above my head. On May 5, 2016 face swelling, chest discomfort May 19 right leg swelling.
Very sore left arm starting on 01/27/2021 - on  1/29/21 woke up with very blurry eyes and pink eye - called my pcp and she prescribed eye drops to be used for 7 days.  The blurry eyes lasted 2 days and gradually cleared up  - My eyes are still slightly blurry.  eights days after the covid shot - my heart started beating at a fast pace - lasted for a few minutes .  at random it  beats fast and then slows to a normal beat.
I experienced pain under my right arm that spread to my side (lymph nodes). Four days later this pain spread to my other arm/side and then a week after that, the soreness spread to the breasts. During this time, I began spotting (although I am in menopause). In the 4th week after the booster shot I started bleeding as though I am menstruating. Please note: I had a breakthrough case of Covid in October (I was fully vaccinated in March 2021) and I received an antibody injection due to the severity of my case. My doctor told me to wait at least one month after Covid before receiving the booster shot. I waited six weeks. However, I read online the suggestion is now to wait three months. I've also read online a small number of women experienced vaginal bleeding post-menopause.
For 40 hours (2 nights and 1 day) Fever, Chills, Head Aches, Soreness all over body, fatigue, inability to sleep, no mental capacity for even basic  activity such as reading or watching TV. I would rate this as on par with worst sicknesses I have ever had in my life. For next approx. 30 hours - soreness all over body, head aches, not as bad as previous day.  Next 24 hours - Soreness on right side, akin to being hit by a baseball fastball in 4 spots on my right side (arm, leg, 2 spots on body) about every 5 minutes. Next 24 hours leg every muscle from knee to hip was sore and hardly moveable like I had participated in an all day sporting event the day before.  For the next week or so I had aftershock headaches, occassional mild headaches that would last for less then a minute. Gradually went down in duration and frequency over time.  Also that next week, felt very fatigued and low energy.
Unbearable lower back and hip pain. Was up at  2:30  am and the rest of the night. And shoulder pain where shot was administerd
3rd dose of hepatitis B vaccine not received; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 20-year-old female patient who received HBV (Engerix B) for prophylaxis.   Previously administered products included Heplisav (received a dose of the expedited hepatitis b vaccine on 30th August 2022) and Engerix B (received a dose on 4th October 2022 with batch number 782YL and expiry date 25th February 2024).   On an unknown date, the patient did not receive Engerix B. On an unknown date, unknown after receiving Engerix B, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 04-JAN-2023 Reporter's Comments: The pharmacist stated that a patient had not had any additional doses of Engerix-B since that time. The reporter gave permission for follow-up. Additional Supportive Information: Till the time of reporting, the patient did not receive a dose of Engerix-B, which led to incomplete course of vaccination.
The evening subsequent to receiving vax, the pt developed diarrhea, and giant hives the size of silver dollars which started on her lower back, then spread to arms, legs, hands and bottoms of feet. Her face was red but had no hives. She was jittery and had a headache. The pt was seen by a physician who treated her with an injection of Donnatal and prednisone. She was also given liquid Benadryl. It was noted that there was no swelling at the injection site. After she finished the prednisone treatment, the rash resolved. Medications were stopped. The pt reported having esophageal spasms which consisted of difficulty swallowing in the muscular part of the throat, which resolved. She had no problems breathing. The pt was seen by a dermatologist. Her clothing causing her discomfort and caused break-out hives. The dermatologist prescribed prednisone5 mg X 7 daily to be tapered over 10 days. After the therapy was completed the pt noticed throbbing joint aches in hands, knees, feet and back. The pt believed that these joint aches had started shortly after vax but had been masked by steroid therapy. This symptom is ongoing. Additionally the pt feels tired and is sleeping more. On 10/04/1999 the pt felt itching at the bottom of her back. On 10/28/1999 she was seen by an allergist who found that the pt is allergic to Engerix B. The most recent information received reports the condition of the pt is not resolved.
This spontaneous report as received from a registered nurse refers to a currently 16 year old patient of unknown gender. There was no information about the patient's concomitant medications, allergies and pertinent medical history reported. On 25-JUN-2015, the patient was vaccinated with the first dose of GARDASIL injection (dose, route of administration, anatomical location of administration, lot# and expiry date were not reported). On 03-JAN-2017, the patient received the second dose in series with GARDASIL 9 (dose, route of administration, anatomical location of administration, lot# and expiry date were not reported). No adverse effects were reported. Additional information has been requested.
This case was reported by a healthcare professional and described the occurrence of crying in a 7-week-old female subject who was vaccinated with KINRIX (GlaxoSmithKline). Concurrent vaccination included PENTACEL (non-GSK manufacturer), ENGERIX B (GlaxoSmithKline) and ROTATEQ (Merck) all given on 30 April 2012. On 30 April 2012 the 7 week old subject inadvertently received a dose of KINRIX at 0.5ml in the left leg. The subject experienced inappropriate age at vaccine administration, wrong vaccine administered, vaccine administered at inappropriate site and overdose. The subject received a dose of KINRIX instead of PREVNAR which resulted in overdose given that she received PENTACEL as well. KINRIX is indicated for administration in the deltoid. On 06 May 2012, less than one week after vaccination with KINRIX, the mother of the subject called the office to report that the baby was crying for 1 and a half hours and was difficult to console. At the time of reporting the outcome of the events was unspecified.
Approximately 5cm x 4cm area of erythema with warmth and induration on the left shoulder following TDAP vaccine  G3P2 vaccinated at 28 weeks as part of routine prenatal care. EDD is 5/26/22. At time of report, patient is still pregnant.
I have had extreme pain in my arm, from my neck down to my wrist, from 4 hours after receiving the COVID vaccine until now--more than 48 hours later. I have been taking Tylenol and Ibuprofen and using a cold compress, but nothing helps with the pain.  I cannot lift my arm more than 1/2 inch from my side without excruciating pain. In addition, I have been running a fever of  100-101.5, possibly a little higher.
Arm felt stiff and immobile after the shot. Patient tried TYLENOL and Ibuprofen. Still not able to move arm after 2 weeks. She felt as though the shot was given too high up near the shoulder.
Immediately after patient felt dizzy and nausea. The next morning she had near syncope with fall after getting out of the shower.
Chest Pain (left side, just under peck) 11/09 , went to see Dr 11/14 , got an EKG and all looked good. Planning on getting an Echo on 11/28 and Blood Work on 11/18 to see why chest pain is occuring.
3 weeks after getting MMR vaccine, patient displayed mild parotitis clinically. Left side of face swollen and red. Questionable virus versus MMR reaction.
Difficulty breathing; swelling of my face and thoat; a fast heartbeat; bad rash all over my body;
Hives starting 2 hours after vaccine administration, itchy, unable to sleep, fatigue, tiredness Allergy medication provided temporary relief
tested positive for COVID-19; tested positive for COVID-19; This is a spontaneous report from a contactable consumer (patient) via a Pfizer sponsored program. A 39-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, unknown lot number and expiration), via an unspecified route of administration on 24Dec2020 at a single dose for him to not get COVID.  Medical history and concomitant medications reported as none.  The patient is a surgical technician who received his first dose of vaccine on 24Dec2020 and tested positive for COVID-19 on 05Jan2021.  Patient's quarantine ends tomorrow, and he is also due for his second dose, tomorrow (14Jan2021).  He is asking what to do as far as taking it or not. Outcome of the events was unknown.   Information on the lot/batch number has been requested.
No additional adverse effects reported; One patient was administered improperly stored PNEUMOVAX 23; This spontaneous report was received from a medical assistant regarding a 66-year-old patient of unknown gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, previous drug reactions or allergies were not reported.  On 03-FEB-2020 the patient was vaccinated with an improperly stored pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, prefilled syringe (strength, dose, route of administration and vaccination scheme were not reported; lot number S024808 was determined to be valid, expiration date 02-JUN-2021) as prophylaxis (product storage error). The storage temperature above 47 degrees Fahrenheit (°F) was 46.6 °F for a timeframe of 13 minutes. There was no previous temperature excursion and the call was made due to a digital data logger. No additional adverse effects were reported.
Moderna Covid 19  Vaccine EUA I spiked a fever, felt nauseous and threw up, and I have arm pain as well as swollen lymph nodes. Also, my body feels very sore and weak. I couldn?t sleep, and I have a raging headache behind my eyes.
sweating; This case was reported by a pharmacist via call center representative and described the occurrence of excess sweating in a 73-year-old male patient who received Herpes zoster (Shingrix) (batch number XC972, expiry date 29th August 2021) for prophylaxis.   On 26th June 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 26th June 2019, immediately after receiving Shingrix, the patient experienced excess sweating. On 26th June 2019, the outcome of the excess sweating was recovered/resolved.   It was unknown if the reporter considered the excess sweating to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in left deltoid. The pharmacist just administered the Shingrix vaccine, to a patient and patient was experiencing excessive sweating.
Dizziness, feeling faint, nausea, feeling feverish, tiredness, and neck pain.